TG693
TG693 is an orally active inhibitor of CLK1. TG693 regulates the mutated exon 31 of the dystrophin gene in vivo. TG693 is used in Duchenne muscular dystrophy (DMD) research[1].
Product Specifications
CAS Number
885272-55-9
UNSPSC
12352005
Hazard Statement
H302
Target
CDK; Dystrophin
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Cytoskeleton
Applications
Cancer-Kinase/protease
Field of Research
Others
Assay Protocol
https://www.medchemexpress.com/tg693.html
Purity
99.95
Solubility
DMSO : 33.33 mg/mL (ultrasonic; warming; heat to 60°C)
Smiles
C12=C(NN=C2)C=CC(C3=CC=NC=C3)=C1
Molecular Formula
C12H9N3
Molecular Weight
195.22
Precautions
H302
References & Citations
[1]Sako Y, et al. Development of an orally available inhibitor of CLK1 for skipping a mutated dystrophin exon in Duchenne muscular dystrophy. Sci Rep. 2017 May 30;7:46126.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
MBS1323403 Inquire
Recombinant Equine herpesvirus 1 Alpha trans-inducing factor 82 kDa protein (14), partial
Sign In for Pricing
View Details 
MBS2580334-01 0.02 mg
Recombinant Human B2M/beta2-MG Protein (His Tag)
Sign In for Pricing
View Details